Dr. Clarisse Ingabire is a veterinarian, public health specialist, and international development expert with more than two decades of experience advancing animal health, food security, and sustainable livestock development across Africa and globally. She currently serves as Global Livestock Specialist at the World Bank, where she supports countries in strengthening livestock systems through investments in animal health, One Health, climate-smart agriculture, and sustainable livestock transformation.

It is truly a pleasure to celebrate two consecutive years of publication and to have you as part of this growing global community dedicated...

A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.

Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.

Introduction: The Innovation Gap We Can No Longer Ignore Vaccines save millions of lives every year—yet millions still miss them. Not because we lack vaccines,...

Introduction: Fractional dosing—defined as the administration of a reduced quantity of antigen compared to the standard licensed dose—has evolved from a contingency approach into a...

The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages...

During the development of the COVID-19 vaccines, regulatory agencies accepted reliance on already existing data from vaccines based on the same technology. This leveraging of existing data, the so-called ‘prior knowledge’, was not new in vaccine development. For example, seasonal influenza vaccines’ reliance on related authorised strains minimises data required for annual updates.